Capital Advantage’s iShares MSCI Emerging Markets ETF EEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.09M Sell
74,437
-1,409
-2% -$92K 0.62% 34
2026
Q1
$4.31M Buy
75,846
+135
+0.2% +$7.94K 0.56% 32
2025
Q4
$4.14M Sell
75,711
-1,036
-1% -$56.3K 0.56% 30
2025
Q3
$4.1M Sell
76,747
-1,460
-2% -$73.3K 0.62% 31
2025
Q2
$3.77M Buy
78,207
+4,997
+7% +$225K 0.6% 31
2025
Q1
$3.06M Hold
73,210
0.56% 33
2024
Q4
$3.06M Buy
+73,210
New +$3.24M 0.56% 33

Other funds holding EEM

Capital Advantage's EEM Position: Q2 2026 in Review

Capital Advantage reduced its iShares MSCI Emerging Markets ETF (EEM) stake by 1.9% in Q2 2026, selling an estimated $92K and leaving 74,437 shares worth $5.09M. The position accounts for 0.62% of the portfolio, ranked #34.

Capital Advantage first reported a position in EEM in Q4 2024 and has held it in 7 quarters since. 1,651 funds tracked by Wall St. Rank hold EEM as of Q2 2026.

  • Capital Advantage held 74,437 shares of iShares MSCI Emerging Markets ETF worth $5.09M as of Q2 2026.
  • Capital Advantage sold 1,409 iShares MSCI Emerging Markets ETF shares in Q2 2026, an estimated $92K.
  • iShares MSCI Emerging Markets ETF made up 0.62% of Capital Advantage's portfolio in Q2 2026, its #34 holding.
  • Capital Advantage first reported a position in iShares MSCI Emerging Markets ETF in Q4 2024 and has held it in 7 quarters since.
  • 1,651 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ETF as of Q2 2026.

Based on Capital Advantage's 13F filing for Q2 2026, filed 13 Jul 2026.